{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T02:27:00Z","timestamp":1767925620649,"version":"3.49.0"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,23]],"date-time":"2025-05-23T00:00:00Z","timestamp":1747958400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejradiology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Radiology"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.ejrad.2025.112179","type":"journal-article","created":{"date-parts":[[2025,5,17]],"date-time":"2025-05-17T22:39:27Z","timestamp":1747521567000},"page":"112179","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Evaluation of recall rates in the Irish national breast screening programme: Insights from two million screening mammograms"],"prefix":"10.1016","volume":"189","author":[{"given":"Sophie","family":"Murphy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Therese","family":"Mooney","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Niall","family":"Phelan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alan","family":"Smith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Louise","family":"Campbell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alissa","family":"Connors","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aideen","family":"Larke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sorcha","family":"McNally","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patricia","family":"Fitzpatrick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maeve","family":"Mullooly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fidelma","family":"Flanagan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejrad.2025.112179_b0005","unstructured":"A short guide to cancer screening Increase effectiveness, maximize benefits and minimize harm. 2022 [cited 2024 Apr 4]; Available from: http:\/\/apps.who.int\/bookorders."},{"key":"10.1016\/j.ejrad.2025.112179_b0010","doi-asserted-by":"crossref","unstructured":"Lauby-Secretan B, Scoccianti C, Loomis D, Benbrahim-Tallaa L, Bouvard V, Bianchini F, et al. Breast-Cancer Screening-Viewpoint of the IARC Working Group. n engl j med [Internet]. 2015 [cited 2022 Nov 16];24:37Available from: http:\/\/handbooks.iarc.fr.","DOI":"10.1056\/NEJMsr1504363"},{"key":"10.1016\/j.ejrad.2025.112179_b0015","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.ejca.2019.12.010","article-title":"Evidence for reducing cancer-specific mortality due to screening for breast cancer in Europe: a systematic review on behalf of the EU-TOPIA consortium 1","volume":"127","author":"Zielonke","year":"2020","journal-title":"Eur. J. Cancer."},{"key":"10.1016\/j.ejrad.2025.112179_b0020","unstructured":"Rauscher GH, Murphy AM, Qiu Q, Dolecek TA, Tossas K, Liu Y, et al. The \u201cSweet Spot\u201d Revisited: Optimal Recall Rates for Cancer Detection With 2D and 3D Digital Screening Mammography in the Metro Chicago Breast Cancer Registry. [cited 2024 Mar 20]; Available from: www.ajronline.org."},{"issue":"1","key":"10.1016\/j.ejrad.2025.112179_b0025","doi-asserted-by":"crossref","first-page":"208","DOI":"10.2214\/AJR.15.15987","article-title":"Recall and cancer detection rates for screening mammography: finding the sweet spot","volume":"208","author":"Grabler","year":"2017","journal-title":"AJR Am. J. Roentgenol."},{"key":"10.1016\/j.ejrad.2025.112179_b0030","doi-asserted-by":"crossref","unstructured":"Perry N, Broeders M, de Wolf C, T\u00f6rnberg S, Holland R, von Karsa L. European guidelines for quality assurance in breast cancer screening and diagnosis. Fourth edition - Summary document. Ann Oncol [Internet]. 2008 Apr 1 [cited 2024 Apr 4];19(4):614\u201322. Available from: http:\/\/www.annalsofoncology.org\/article\/S0923753419414348\/fulltext.","DOI":"10.1093\/annonc\/mdm481"},{"key":"10.1016\/j.ejrad.2025.112179_b0035","unstructured":"Partnership Against Cancer C. Abnormal Call Rates for Breast Cancer Screening. 2019."},{"issue":"4","key":"10.1016\/j.ejrad.2025.112179_b0040","doi-asserted-by":"crossref","first-page":"256","DOI":"10.7326\/M15-0970","article-title":"Harms of breast cancer screening: Systematic review to update the 2009 U.S. Preventive services task force recommendation","volume":"164","author":"Nelson","year":"2016","journal-title":"Ann. Intern. Med."},{"issue":"4","key":"10.1016\/j.ejrad.2025.112179_b0045","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1177\/0969141317738034","article-title":"Evolution of the national breast screening programme in Ireland: two-year interval analysis (2004-2013) of breastcheck","volume":"25","author":"Fitzpatrick","year":"2018","journal-title":"J. Med. Screen."},{"issue":"16","key":"10.1016\/j.ejrad.2025.112179_b0050","doi-asserted-by":"crossref","first-page":"3517","DOI":"10.1016\/j.ejca.2013.06.020","article-title":"Nation-wide data on screening performance during the transition to digital mammography: observations in 6 million screens","volume":"49","author":"Van Luijt","year":"2013","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.ejrad.2025.112179_b0055","unstructured":"Main Report - NHS England Digital [Internet]. [cited 2024 Apr 10]. Available from: https:\/\/digital.nhs.uk\/data-and-information\/publications\/statistical\/breast-screening-programme\/england---2020-21\/mainreport6#section-5-outcome-of-screening."},{"key":"10.1016\/j.ejrad.2025.112179_b0060","doi-asserted-by":"crossref","unstructured":"Hambly NM, McNicholas MM, Phelan N, Hargaden GC, O\u2019Doherty A, Flanagan FL, et al. Comparison of Digital Mammography and Screen-Film Mammography in Breast Cancer Screening: A Review in the Irish Breast Screening Program. https:\/\/doi.org\/102214\/AJR082157 [Internet]. 2012 Nov 23 [cited 2024 Aug 8];193(4):1010\u20138. Available from: https:\/\/ajronline.org\/doi\/10.2214\/AJR.08.2157.","DOI":"10.2214\/AJR.08.2157"},{"issue":"6","key":"10.1016\/j.ejrad.2025.112179_b0065","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1159\/000503715","article-title":"National breast screening programs across Europe","volume":"14","author":"Peintinger","year":"2019","journal-title":"Breast Care"},{"key":"10.1016\/j.ejrad.2025.112179_b0070","unstructured":"Scally G. Scoping Inquiry into the CervicalCheck Screening Programme Scoping Inquiry into the CervicalCheck Screening Programme Final Report i. 2018;."},{"issue":"8","key":"10.1016\/j.ejrad.2025.112179_b0075","article-title":"Mining google trends data for health information: the case of the irish \u201ccervicalcheck\u201d screening programme revelations","volume":"11","author":"Ryan","year":"2019","journal-title":"Cureus"},{"key":"10.1016\/j.ejrad.2025.112179_b0080","article-title":"Trust and cancer screening: effects of a screening controversy on women\u2019s perceptions of cervical cancer screening","volume":"25","author":"O\u2019Donovan","year":"2021","journal-title":"Prev. Med. Rep."},{"key":"10.1016\/j.ejrad.2025.112179_b0085","doi-asserted-by":"crossref","unstructured":"Shaw CM, Flanagan F, Fenlon HM, McNicholas MM. Consensus Review of Discordant Findings Maximizes Cancer Detection Rate in Double-Reader Screening Mammography: Irish National Breast Screening Program Experience1. https:\/\/doi.org\/101148\/radiol2502080224 [Internet]. 2009 Feb 1 [cited 2025 Feb 14];250(2):354\u201362. Available from: https:\/\/pubs.rsna.org\/doi\/10.1148\/radiol.2502080224.","DOI":"10.1148\/radiol.2502080224"},{"issue":"1","key":"10.1016\/j.ejrad.2025.112179_b0090","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1148\/radiol.2020181454","article-title":"Consensus review of discordant imaging findings after the introduction of digital screening mammography: Irish national breast cancer screening program experience","volume":"295","author":"Healy","year":"2020","journal-title":"Radiology"},{"key":"10.1016\/j.ejrad.2025.112179_b0095","unstructured":"BreastCheck Important information about your breast screening. [cited 2024 Mar 20]; Available from: www.breastcheck.ie."},{"key":"10.1016\/j.ejrad.2025.112179_b0100","unstructured":"Annual reports [Internet]. [cited 2024 Mar 20]. Available from: https:\/\/www.breastcheck.ie\/health-professionals\/annual-reports.2720.html."},{"key":"10.1016\/j.ejrad.2025.112179_b0105","unstructured":"Union PO of the E. European guidelines for quality assurance in breast cancer screening and diagnosis\u00a0: fourth edition, supplements. 2013 Oct 16 [cited 2024 Apr 5]; Available from: https:\/\/op.europa.eu\/en\/publication-detail\/-\/publication\/4e74ee9b-df80-4c91-a5fb-85efb0fdda2b."},{"issue":"5","key":"10.1016\/j.ejrad.2025.112179_b0110","doi-asserted-by":"crossref","first-page":"R11","DOI":"10.1186\/bcr455","article-title":"Impact of false-positive mammography on subsequent screening attendance and risk of cancer","volume":"4","author":"McCann","year":"2002","journal-title":"Breast Cancer Res."},{"issue":"1","key":"10.1016\/j.ejrad.2025.112179_b0115","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1258\/jms.2010.010104","article-title":"False-positive mammographic screening: factors influencing re-attendance over a decade of screening","volume":"18","author":"Fitzpatrick","year":"2011","journal-title":"J. Med Screen."},{"issue":"1","key":"10.1016\/j.ejrad.2025.112179_b0120","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1093\/jnci\/djaa080","article-title":"Impact of full-field digital mammography versus film-screen mammography in population screening: a meta-analysis","volume":"113","author":"Farber","year":"2021","journal-title":"JNCI J. Natl. Cancer Inst."},{"issue":"4","key":"10.1016\/j.ejrad.2025.112179_b0125","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1177\/0969141317738034","article-title":"Evolution of the national breast screening programme in Ireland: two-year interval analysis (2004\u20132013) of Breast Check","volume":"25","author":"Fitzpatrick","year":"2018","journal-title":"J. Med. Screen."},{"issue":"6","key":"10.1016\/j.ejrad.2025.112179_b0130","doi-asserted-by":"crossref","first-page":"524","DOI":"10.3322\/caac.21754","article-title":"Breast Cancer Statistics, 2022","volume":"72","author":"Giaquinto","year":"2022","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.ejrad.2025.112179_b0135","unstructured":"What Are the Risk Factors for Breast Cancer? | CDC [Internet]. [cited 2024 Apr 5]. Available from: https:\/\/www.cdc.gov\/cancer\/breast\/basic_info\/risk_factors.htm."},{"key":"10.1016\/j.ejrad.2025.112179_b0140","unstructured":"Department of Health (DOH 2019). Healthy Ireland. [cited 2024 Apr 5]; Available from: https:\/\/assets.gov.ie\/41141\/e5d6fea3a59a4720b081893e11fe299e.pdf."},{"key":"10.1016\/j.ejrad.2025.112179_b0145","unstructured":"Hormone Replacement Therapy - England - April 2015 to June 2023 | NHSBSA [Internet]. [cited 2024 Mar 20]. Available from: https:\/\/www.nhsbsa.nhs.uk\/statistical-collections\/hormone-replacement-therapy-england\/hormone-replacement-therapy-england-april-2015-june-2023."},{"issue":"2","key":"10.1016\/j.ejrad.2025.112179_b0150","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1148\/radiology.196.2.7617857","article-title":"Effect of postmenopausal hormonal replacement therapy on mammographic density and parenchymal pattern","volume":"196","author":"Laya","year":"1995","journal-title":"Radiology"},{"issue":"6","key":"10.1016\/j.ejrad.2025.112179_b0155","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/S0009-9260(05)80566-5","article-title":"The mammographic parenchymal patterns of women on hormonal replacement therapy","volume":"43","author":"Kaufman","year":"1991","journal-title":"Clin. Radiol."},{"key":"10.1016\/j.ejrad.2025.112179_b0160","unstructured":"Breast Response with Hormone Replacement Therapy. Diagnostic Breast Imaging. 2014 Jun 7."},{"issue":"6","key":"10.1016\/j.ejrad.2025.112179_b0165","doi-asserted-by":"crossref","first-page":"4036","DOI":"10.1007\/s00330-022-08617-6","article-title":"Breast cancer screening in women with extremely dense breasts recommendations of the European Society of Breast Imaging (EUSOBI)","volume":"32","author":"Mann","year":"2022","journal-title":"Eur. Radiol."},{"key":"10.1016\/j.ejrad.2025.112179_b0170","unstructured":"Committee of Public Accounts to examine 2021 Financial Statements of State Claims Agency \u2013 1 Mar 2023, 17:55 \u2013 Houses of the Oireachtas [Internet]. [cited 2024 Apr 4]. Available from: https:\/\/www.oireachtas.ie\/en\/press-centre\/press-releases\/20230301-committee-of-public-accounts-to-examine-2021-financial-statements-of-state-claims-agency\/."},{"key":"10.1016\/j.ejrad.2025.112179_b0175","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1136\/bmjoq-2023-002433","article-title":"Current Irish medicolegal landscape: an unsustainable trajectory","volume":"12","author":"Forrest","year":"2023","journal-title":"BMJ Open Qual."},{"issue":"21","key":"10.1016\/j.ejrad.2025.112179_b0180","doi-asserted-by":"crossref","first-page":"2609","DOI":"10.1001\/jama.293.21.2609","article-title":"Defensive medicine among high-risk specialist physicians in a volatile malpractice environment","volume":"293","author":"Studdert","year":"2005","journal-title":"JAMA"},{"issue":"11","key":"10.1016\/j.ejrad.2025.112179_b0185","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1038\/bjc.2016.90","article-title":"Meta-analysis of breast cancer mortality benefit and overdiagnosis adjusted for adherence: improving information on the effects of attending screening mammography","volume":"114","author":"Jacklyn","year":"2016","journal-title":"Br. J. Cancer."},{"issue":"22","key":"10.1016\/j.ejrad.2025.112179_b0190","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1001\/jamainternmed.2013.10363","article-title":"Less is more: Overdiagnosis and overtreatment: evaluation of what physicians tell their patients about screening harms","volume":"173","author":"Wegwarth","year":"2013","journal-title":"JAMA Intern. Med."},{"key":"10.1016\/j.ejrad.2025.112179_b0195","doi-asserted-by":"crossref","unstructured":"Lauby-Secretan B, Scoccianti C, Loomis D, Benbrahim-Tallaa L, Bouvard V, Bianchini F, et al. Breast-Cancer Screening-Viewpoint of the IARC Working Group. n engl j med [Internet]. 2015 [cited 2024 Aug 7];24:372. Available from: http:\/\/handbooks.iarc.fr.","DOI":"10.1056\/NEJMsr1504363"},{"key":"10.1016\/j.ejrad.2025.112179_b0200","doi-asserted-by":"crossref","unstructured":"Lauby-Secretan B, Scoccianti C, Loomis D, Benbrahim-Tallaa L, Bouvard V, Bianchini F, et al. Breast-Cancer Screening-Viewpoint of the IARC Working Group. n engl j med [Internet]. 2015 [cited 2024 Mar 20];24:372. Available from: http:\/\/handbooks.iarc.fr.","DOI":"10.1056\/NEJMsr1504363"},{"key":"10.1016\/j.ejrad.2025.112179_b0205","unstructured":"Expert Reference Group Report Response from Faculty - Faculty of Radiologists [Internet]. [cited 2025 Feb 16]. Available from: https:\/\/www.radiology.ie\/news\/107-expert-reference-group-report-response-from-faculty."},{"issue":"3","key":"10.1016\/j.ejrad.2025.112179_b0210","doi-asserted-by":"crossref","first-page":"e56","DOI":"10.1016\/j.clbc.2023.01.009","article-title":"Do reader characteristics affect diagnostic efficacy in screening mammography? a systematic review","volume":"23","author":"Wong","year":"2023","journal-title":"Clin. Breast Cancer."},{"issue":"9","key":"10.1016\/j.ejrad.2025.112179_b0215","doi-asserted-by":"crossref","first-page":"6909","DOI":"10.1007\/s00330-021-07754-8","article-title":"Optimum screening mammography reading volumes: evidence from the NHS Breast Screening Programme","volume":"31","author":"Cornford","year":"2021","journal-title":"Eur. Radiol."},{"issue":"3","key":"10.1016\/j.ejrad.2025.112179_b0220","doi-asserted-by":"crossref","first-page":"e175","DOI":"10.1016\/S2589-7500(24)00267-X","article-title":"Screening performance and characteristics of breast cancer detected in the Mammography Screening with Artificial Intelligence trial (MASAI): a randomised, controlled, parallel-group, non-inferiority, single-blinded, screening accuracy study","volume":"7","author":"Hernstr\u00f6m","year":"2025","journal-title":"Lancet Digit Heal."},{"issue":"3","key":"10.1016\/j.ejrad.2025.112179_b0225","doi-asserted-by":"crossref","DOI":"10.1148\/radiol.242566","article-title":"Human-AI Interaction in the ScreenTrustCAD Trial: recall proportion and positive predictive value related to screening mammograms flagged by AI CAD versus a human reader","volume":"314","author":"Dembrower","year":"2025","journal-title":"Radiology"},{"key":"10.1016\/j.ejrad.2025.112179_b0230","doi-asserted-by":"crossref","DOI":"10.1016\/j.pmedr.2023.102405","article-title":"How is equity captured for colorectal, breast and cervical cancer incidence and screening in the Republic of Ireland: a review","volume":"36","author":"Mulcahy Symmons","year":"2023","journal-title":"Prev. Med. Reports"}],"container-title":["European Journal of Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0720048X25002657?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0720048X25002657?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,7]],"date-time":"2025-06-07T18:57:21Z","timestamp":1749322641000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0720048X25002657"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":46,"alternative-id":["S0720048X25002657"],"URL":"https:\/\/doi.org\/10.1016\/j.ejrad.2025.112179","relation":{},"ISSN":["0720-048X"],"issn-type":[{"value":"0720-048X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of recall rates in the Irish national breast screening programme: Insights from two million screening mammograms","name":"articletitle","label":"Article Title"},{"value":"European Journal of Radiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejrad.2025.112179","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"112179"}}